UPClytics
View all cases

UPC CFI 2819/2026

Aug 5, 2026·EP2401365 · REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Case details
Status
Case Closed
Action
Other
Category
Other procedural
Parties
Claimants
Representatives
Respondents
Representatives
Division
Munich LD
Technology
  • Chemistry
    Biotechnology
Language
English
First decided
Sep 28, 2026
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Munich LDLocked
Judge Daniel VossLocked
Judge András KupeczLocked
Judge Georg WernerLocked
Judge Martin SchmidtLocked

At the UPC: The Scripps Research Institute (7 cases)·BioNTech Group (21 cases)

Decisions
  • 2026-09-28
    other

    Summary: Decision in cost proceedings after the Munich LD merits decision of 7 July 2026 (EP 2 401 365 revoked, Promosome's infringement actions dismissed): Promosome and The Scripps Research Institute are ordered jointly and severally to pay each defendant group (BioNTech, defendants 1-5; Pfizer, defendants 6-9) EUR 750,000 in recoverable costs, as agreed, satisfied by release of the EUR 1.5m security for costs deposited under the order of 9 April 2025; the cost proceedings close on transfer.

    Show the legal issues (3)
    • Cost decision under R. 150, 151 and 156.3 RoP following an agreed flat-fee reimbursement
    • Release of security for costs to satisfy a costs award (R. 352.2 RoP by analogy)
    • No costs decision for the cost proceedings themselves
Documents
Document titleDatePublic
Case closed2026-09-28Not public
Decision2026-09-28Public
Decision2026-09-14Not public
Decision2026-09-14Not public
Publication2026-09-09Not public
Receipt2026-09-03Not public
Cover sheet2026-09-03Not public
Document2026-09-03Not public
Communication2026-09-02Not public
Receipt2026-09-01Not public
Cover sheet2026-09-01Not public
Document2026-09-01Not public
Receipt2026-08-05Not public
Cover sheet2026-08-05Not public
Application Respondent2026-08-05Not public